Skip to main content

Kaempferol Induces Cell Death Through ERK and Akt-Dependent Down-Regulation of XIAP and Survivin in Human Glioma Cells

Neurochemical Research volume 34, pages 991–1001 (2009)Cite this article

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

The present study was undertaken to determine the molecular mechanism by which kaempferol induces cell death in human glioma cells. Kaempferol resulted in loss of cell viability and inhibition of proliferation in a dose- and time-dependent manner, which were largely attributed to cell death. Kaempferol caused an increase in reactive oxygen species (ROS) generation and the kaempferol-induced cell death was prevented by antioxidants, suggesting that ROS generation is involved in kaempferol-induced cell death. Kaempferol caused depolarization of mitochondrial membrane potential. Western blot analysis showed that kaempferol treatment caused a rapid reduction in phosphorylation of extracellular signal-regulated kinase (ERK) and Akt. The ERK inhibitor U0126 and the Akt inhibitor LY984002 increased the kaempferol-induced cell death and overexpression of MEK, the upstream kinase of ERK, and Akt prevented the cell death. The expression of anti-apoptotic proteins XIAP and survivin was down-regulated by kaempferol and its effect was prevented by overexpression of MEK and Akt. Kaempferol induced activation of caspase-3 and kaempferol-induced cell death was prevented by caspase inhibitors. Taken together, these findings suggest that kaempferol results in human glioma cell death through caspase-dependent mechanisms involving down-regulation of XIAP and survivin regulating by ERK and Akt.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64(6):479–489

    PubMed  CAS  Google Scholar 

  2. DeAngelis LM (2001) Brain tumors. N Engl J Med 344(2):114–123. doi:10.1056/NEJM200101113440207

    Article  Google Scholar 

  3. Middleton E Jr, Kandaswami C, Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52(4):673–751

    PubMed  CAS  Google Scholar 

  4. Yang JH, Hsia TC, Kuo HM, Chao PD, Chou CC, Wei YH, Chung JG (2006) Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos 34(2):296–304. doi:10.1124/dmd.105.005280

    Article  PubMed  CAS  Google Scholar 

  5. Kanadaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT, Lee MT (2005) The antitumor activities of flavonoids. In Vivo 19(5):895–909

    PubMed  CAS  Google Scholar 

  6. Ren W, Qiao Z, Wang H, Zhu L, Zhang L (2003) Flavonoids: promising anticancer agents. Med Res Rev 23(4):519–534. doi:10.1002/med.10033

    Article  PubMed  CAS  Google Scholar 

  7. Fresco P, Borges F, Diniz C, Marques MP (2006) New insights on the anticancer properties of dietary polyphenols. Med Res Rev 26(6):747–766. doi:10.1002/med.20060

    Article  PubMed  CAS  Google Scholar 

  8. Braganhol E, Zamin LL, Canedo AD, Horn F, Tamajusuku AS, Wink MR, Salbego C, Battastini AM (2006) Antiproliferative effect of quercetin in the human U138MG glioma cell line. Anticancer Drugs 17(6):663–671. doi:10.1097/01.cad.0000215063.23932.02

    Article  PubMed  CAS  Google Scholar 

  9. Shen SC, Lin CW, Lee HM, Chien LL, Chen YC (2006) Lipopolysaccharide plus 12-o-tetradecanoylphorbol 13-acetate induction of migration and invasion of glioma cells in vitro and in vivo: Differential inhibitory effects of flavonoids. Neuroscience 140(2):477–489. doi:10.1016/j.neuroscience.2006.02.028

    Article  PubMed  CAS  Google Scholar 

  10. Sharma V, Joseph C, Ghosh S, Agarwal A, Mishra MK, Sen E (2007) Kaempferol induces apoptosis in glioblastoma cells through oxidative stress. Mol Cancer Ther 6(9):2544–2553. doi:10.1158/1535-7163.MCT-06-0788

    Article  PubMed  CAS  Google Scholar 

  11. Leung HW, Lin CJ, Hour MJ, Yang WH, Wang MY, Lee HZ (2007) Kaempferol induces apoptosis in human lung non-small carcinoma cells accompanied by an induction of antioxidant enzymes. Food Chem Toxicol 45(10):2005–2013. doi:10.1016/j.fct.2007.04.023

    Article  PubMed  CAS  Google Scholar 

  12. Nguyen TT, Tran E, Ong CK, Lee SK, Do PT, Huynh TT, Nguyen TH, Lee JJ, Tan Y, Ong CS, Huynh H (2003) Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK. J Cell Physiol 197(1):110–121. doi:10.1002/jcp.10340

    Article  PubMed  CAS  Google Scholar 

  13. Dimas K, Demetzos C, Mitaku S, Marselos M, Tzavaras T, Kokkinopoulos D (2000) Cytotoxic activity of kaempferol glycosides against human leukaemic cell lines in vitro. Pharmacol Res 41(1):85–88. doi:10.1006/phrs.1999.0562

    Article  PubMed  CAS  Google Scholar 

  14. Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89(2):271–277. doi:10.1016/0022-1759(86)90368-6

    Article  PubMed  CAS  Google Scholar 

  15. Pastorino JG, Chen ST, Tafani M, Snyder JW, Farber JL (1998) The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J Biol Chem 273(13):7770–7775. doi:10.1074/jbc.273.13.7770

    Article  PubMed  CAS  Google Scholar 

  16. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270(5240):1326–1331. doi:10.1126/science.270.5240.1326

    Article  PubMed  CAS  Google Scholar 

  17. Cobb MH (1999) MAP kinase pathways. Prog Biophys Mol Biol 71(3–4):479–500. doi:10.1016/S0079-6107(98)00056-X

    Article  PubMed  CAS  Google Scholar 

  18. Coffer PJ, Jin J, Woodgett JR (1998) Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 335(Pt 1):1–13

    PubMed  CAS  Google Scholar 

  19. Fukuda S, Pelus LM (2006) Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 5(5):1087–1098. doi:10.1158/1535-7163.MCT-05-0375

    Article  PubMed  CAS  Google Scholar 

  20. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A, Andreeff M, Reed JC (2000) Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6(5):1796–1803

    PubMed  CAS  Google Scholar 

  21. Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem J 326:1–16

    PubMed  CAS  Google Scholar 

  22. Miura YH, Tomita I, Watanabe T, Hirayama T, Fukui S (1998) Active oxygens generation by flavonoids. Biol Pharm Bull 21(2):93–96

    PubMed  CAS  Google Scholar 

  23. Wang IK, Lin-Shiau SY, Lin JK (1999) Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur J Cancer 35(10):1517–1525. doi:10.1016/S0959-8049(99)00168-9

    Article  PubMed  CAS  Google Scholar 

  24. Chen YC, Shen SC, Chow JM, Ko CH, Tseng SW (2004) Flavone inhibition of tumor growth via apoptosis in vitro and in vivo. Int J Oncol 25(3):661–670

    PubMed  CAS  Google Scholar 

  25. Pastorino JG, Snyder JW, Serroni A, Hoek JB, Farber JL (1993) Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition. J Biol Chem 268(19):13791–13798

    PubMed  CAS  Google Scholar 

  26. Kroemer G, Dallaporta B, Resche-Rigon M (1998) The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60:619–642

    Article  PubMed  CAS  Google Scholar 

  27. Tatton WG, Olanow CW (1999) Apoptosis in neurodegenerative diseases: the role of mitochondria. Biochim Biophys Acta 1410(2):195–213. doi:10.1016/S0005-2728(98)00167-4

    Article  PubMed  CAS  Google Scholar 

  28. Bhaskara VK, Sundaram C, Babu PP (2006) pERK, pAkt and pBad: a possible role in cell proliferation and sustained cellular survival during tumorigenesis and tumor progression in ENU induced transplacental glioma rat model. Neurochem Res 31(9):1163–1170. doi:10.1007/s11064-006-9142-7

    Article  PubMed  CAS  Google Scholar 

  29. Jacques-Silva MC, Bernardi A, Rodnight R, Lenz G (2004) ERK, PKC and PI3 K/Akt pathways mediate extracellular ATP and adenosine-induced proliferation of U138-MG human glioma cell line. Oncology 67(5–6):450–459. doi:10.1159/000082930

    Article  PubMed  CAS  Google Scholar 

  30. Wang L, Liu F, Adamo ML (2001) Cyclic AMP inhibits extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways by inhibiting Rap1. J Biol Chem 276(40):37242–37249. doi:10.1074/jbc.M105089200

    Article  PubMed  CAS  Google Scholar 

  31. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22(2):153–183. doi:10.1210/er.22.2.153

    Article  PubMed  CAS  Google Scholar 

  32. Groom LA, Sneddon AA, Alessi DR, Dowd S, Keyse SM (1996) Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J 15(14):3621–3632

    PubMed  CAS  Google Scholar 

  33. Kortenjann M, Thomae O, Shaw PE (1994) Inhibition of v-raf-dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2. Mol Cell Biol 14(7):4815–4824

    PubMed  CAS  Google Scholar 

  34. Brunet A, Pages G, Pouyssegur J (1994) Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene 9(11):3379–3387

    PubMed  CAS  Google Scholar 

  35. Moon SK, Cho GO, Jung SY, Gal SW, Kwon TK, Lee YC, Madamanchi NR, Kim CH (2003) Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun 301(4):1069–1078. doi:10.1016/S0006-291X(03)00091-3

    Article  PubMed  CAS  Google Scholar 

  36. Singh RP, Tyagi AK, Zhao J, Agarwal R (2002) Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis. Carcinogenesis 23(3):499–510. doi:10.1093/carcin/23.3.499

    Article  PubMed  CAS  Google Scholar 

  37. Spencer JP, Rice-Evans C, Williams RJ (2003) Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem 278(37):34783–34793. doi:10.1074/jbc.M305063200

    Article  PubMed  CAS  Google Scholar 

  38. Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H (2004) The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis 25(5):647–659. doi:10.1093/carcin/bgh052

    Article  PubMed  CAS  Google Scholar 

  39. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Remesy C, Chap H, Payrastre B (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53(11):1649–1657. doi:10.1016/S0006-2952(97)82453-7

    Article  PubMed  CAS  Google Scholar 

  40. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, Williams RL (2000) Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6(4):909–919. doi:10.1016/S1097-2765(05)00089-4

    Article  PubMed  CAS  Google Scholar 

  41. Granado-Serrano AB, Martin MA, Bravo L, Goya L, Ramos S (2006) Quercetin Induces Apoptosis via Caspase Activation, Regulation of Bcl-2, and Inhibition of PI-3-Kinase/Akt and ERK Pathways in a Human Hepatoma Cell Line (HepG2). J Nutr 136(11):2715–2721

    PubMed  CAS  Google Scholar 

  42. Ni T, Li W, Zou F (2005) The ubiquitin ligase ability of IAPs regulates apoptosis. IUBMB Life 57(12):779–785. doi:10.1080/15216540500389013

    Article  PubMed  CAS  Google Scholar 

  43. Liston P, Young SS, Mackenzie AE, Korneluk RG (1997) Life and death decisions: the role of the IAPs in modulating programmed cell death. Apoptosis 2(5):423–441. doi:10.1023/A:1026465926478

    Article  PubMed  CAS  Google Scholar 

  44. Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ, Loeffler JS (2002) Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 20(4):1063–1068. doi:10.1200/JCO.20.4.1063

    Article  PubMed  CAS  Google Scholar 

  45. Kajiwara Y, Yamasaki F, Hama S, Yahara K, Yoshioka H, Sugiyama K, Arita K, Kurisu K (2003) Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Cancer 97(4):1077–1083. doi:10.1002/cncr.11122

    Article  PubMed  Google Scholar 

  46. McLaughlin N, Annabi B, Bouzeghrane M, Temme A, Bahary JP, Moumdjian R, Beliveau R (2006) The Survivin-mediated radioresistant phenotype of glioblastomas is regulated by RhoA and inhibited by the green tea polyphenol (-)-epigallocatechin-3-gallate. Brain Res 1071(1):1–9. doi:10.1016/j.brainres.2005.10.009

    Article  PubMed  CAS  Google Scholar 

  47. Altieri DC (2001) The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 7(12):542–547. doi:10.1016/S1471-4914(01)02243-2

    Article  PubMed  CAS  Google Scholar 

  48. Kim EJ, Choi CH, Park JY, Kang SK, Kim YK (2008) Underlying mechanism of quercetin-induced cell death in human glioma cells. Neurochem Res 33:971–979

    Article  PubMed  CAS  Google Scholar 

  49. Kang DW, Choi CH, Park JY, Kang SK, Kim YK (2008) Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells. Neurochem Res 33(3):551–561. doi:10.1007/s11064-007-9475-x

    Article  PubMed  CAS  Google Scholar 

  50. Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y (2006) Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Cancer 107(4):746–756. doi:10.1002/cncr.22044

    Article  PubMed  CAS  Google Scholar 

  51. Yao LL, Wang YG, Cai WJ, Yao T, Zhu YC (2007) Survivin mediates the anti-apoptotic effect of delta-opioid receptor stimulation in cardiomyocytes. J Cell Sci 120(Pt 5):895–907. doi:10.1242/jcs.03393

    Article  PubMed  CAS  Google Scholar 

  52. Mitchell C, Park MA, Zhang G, Yacoub A, Curiel DT, Fisher PB, Roberts JD, Grant S, Dent P (2007) Extrinsic pathway- and cathepsin-dependent induction of mitochondrial dysfunction are essential for synergistic flavopiridol and vorinostat lethality in breast cancer cells. Mol Cancer Ther 6(12 Pt 1):3101–3112. doi:10.1158/1535-7163.MCT-07-0561

    Google Scholar 

  53. Martindale JL, Holbrook NJ (2002) Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192:1–15

    Article  PubMed  CAS  Google Scholar 

  54. Yang HY, Kim J, Chung GH, Lee JC, Jang YS (2007) Cross-linking of MHC class II molecules interferes with phorbol 12, 13-dibutyrate-induced differentiation of resting B cells by inhibiting Rac-associated ROS-dependent ERK/p38 MAP kinase pathways leading to NF-kappaB activation. Mol Immunol 44(7):1577–1586. doi:10.1016/j.molimm.2006.08.017

    Article  PubMed  CAS  Google Scholar 

  55. Su YT, Chang HL, Shyue SK, Hsu SL (2005) Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochem Pharmacol 70(2):229–241. doi:10.1016/j.bcp.2005.04.026

    Article  PubMed  CAS  Google Scholar 

  56. Rahmani M, Reese E, Dai Y, Bauer C, Payne SG, Dent P, Spiegel S, Grant S (2005) Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. Cancer Res 65(6):2422–2432. doi:10.1158/0008-5472.CAN-04-2440

    Article  PubMed  CAS  Google Scholar 

  57. Lee WC, Choi CH, Cha SH, Oh HL, Kim YK (2005) Role of ERK in hydrogen peroxide-induced cell death of human glioma cells. Neurochem Res 30:263–270

    Article  PubMed  CAS  Google Scholar 

  58. Park BG, Yoo CI, Kim HT, Kwon CH, Kim YK (2005) Role of mitogen-activated protein kinases in hydrogen peroxide-induced cell death in osteoblastic cells. Toxicology 215(1–2):115–125. doi:10.1016/j.tox.2005.07.003

    Article  PubMed  CAS  Google Scholar 

  59. Russo M, Palumbo R, Tedesco I, Mazzarella G, Russo P, Iacomino G, Russo GL (1999) Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line. FEBS Lett 462(3):322–328. doi:10.1016/S0014-5793(99)01544-6

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

This work was supported by the MRC program of MOST/KOSEF (R13-2005-009) in Korea.

Author information

Authors and Affiliations

  1. Department of Oriental Medicine, Dongguk University, Kyung Ju, 780-714, South Korea

    Ji Cheon Jeong & Min Soo Kim

  2. Department of Physiology, College of Medicine, Pusan National University, Pusan, 602-739, South Korea

    Thae Hyun Kim & Yong Keun Kim

  3. MRC for ischemic tissue regeneration, College of Medicine, Pusan National University, Pusan, 602-739, South Korea

    Yong Keun Kim

Authors
  1. Ji Cheon Jeong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Min Soo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thae Hyun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yong Keun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yong Keun Kim.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Jeong, J.C., Kim, M.S., Kim, T.H. et al. Kaempferol Induces Cell Death Through ERK and Akt-Dependent Down-Regulation of XIAP and Survivin in Human Glioma Cells. Neurochem Res 34, 991–1001 (2009). https://doi.org/10.1007/s11064-008-9868-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-008-9868-5

Keywords

  • Kaempferol
  • Cell viability
  • ERK
  • Akt
  • XIAP
  • Survivin
  • Human glioma cells